Detailed View
CTNM - Contineum Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
612,762,688
Adj EBIT (TTM)
-66,853,000
Enterprise Value
366,434,688
Last Price
16.39
Earnings Yield
-18.24%
Return on Capital
-26.25%
Capital
254,692,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -16,904,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -17,115,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -14,932,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -17,902,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -18,110,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -17,046,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -12,974,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -10,944,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.